Phibro’s Animal Health segment delivered $291.2 million of net sales in the quarter, up $32.8 million, or 13%, from the prior-year period. David said Animal Health adjusted EBITDA rose $8 million, or 13%, “due to higher sales and gross profit, partially offset by increased SG&A.”On an adjusted basis, David said adjusted net income and adjusted diluted EPS both increased 19% from the prior year, driven by higher gross profit from higher sales, partially offset by higher SG&A and higher interest expense.Forei ...